The Effect of High Intensity Functional Exercise Programs on Menopausal Symptoms, Physical Performance, and Dual Task Performance in Postmenopausal Women (HIFT-PM)

March 10, 2026 updated by: Uskudar University

The Effect of High-Intensity Functional Exercise Programs on Menopausal Symptoms, Physical Performance, and Dual-Task Performance in Postmenopausal Women

This study was conducted to examine the effects of exercise programs on the physical and psychosocial health of postmenopausal women. The postmenopausal period is characterized by an increased risk of problems such as decreased muscle strength, balance problems, fatigue, stress, and reduced quality of life due to hormonal changes. Therefore, appropriate exercise approaches are crucial during this period.

The study evaluated the effects of regular and planned exercise programs on the physical functions and overall well-being of postmenopausal women.

The study also addressed structured exercise approaches such as high-intensity functional training (HIFT). HIFT consists of short but intense exercises similar to daily activities. However, such exercises should be planned and monitored by healthcare professionals according to the individual's age and health status.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Menopause is a natural process that occurs with the end of a woman's reproductive years, and due to hormonal changes, many physiological, psychological, and functional symptoms are observed. During this period, decreased estrogen levels are associated with sleep disturbances, vasomotor symptoms, fatigue, depressive mood, musculoskeletal complaints, and a significant decrease in quality of life. Exercise is one of the most effective, low-cost, and safe methods to alleviate menopausal symptoms and improve functionality. However, studies investigating the effects of HIFT on menopausal symptoms, physical performance, and dual-task performance in postmenopausal women are quite limited.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • The participant must have had at least 12 months pass since their last menstrual period.
  • The participant must be between 50-65 years of age.
  • The participant must be able to walk independently.
  • The participant must have sufficient cognitive function.

Exclusion Criteria:

  • Neurological disorders
  • Active vestibular disorder
  • Lower extremity surgery or serious orthopedic injury
  • Severe arthritis and pain affecting walking
  • Use of sedative psychoactive drugs
  • Cognitive impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High Intensity Functional Training Group
group that performs high-intensity functional exercises
Behavioral: High-intensity functional exercise
Participants in the exercise group followed a high-intensity functional exercise program designed to improve physical function, menopausal symptoms, and dual-task performance during the postmenopausal period.
Active Comparator: Control Group
moderate to low intensity exercise
Behavioral: moderate to low intensity exercise
Control group participants performed moderate or low-intensity exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
short physical performance battery
Time Frame: 8 weeks

Short Physical Performance Battery (SPPB) is a brief and standardized test battery used to assess lower-extremity physical performance, particularly in older adults. The test evaluates three main functional components: balance, gait speed, and chair-stand performance.

Each subtest is scored between 0 and 4 points, resulting in a total score ranging from 0 to 12. Higher scores indicate better physical performance. The SPPB is widely used in clinical research and geriatric assessments to determine functional capacity, risk of falls, and level of physical independence.
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dual task performance
Time Frame: 8 weeks
Dual-task performance refers to an individual's ability to perform two tasks simultaneously. It is commonly assessed by combining a motor task (such as walking) with a cognitive task (such as counting or word generation) at the same time. This assessment is widely used to examine cognitive-motor interaction, balance control, and fall risk, particularly in older adults.
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Uskudar University

Investigators

  • Study Director: Filiz Eyuboglu, PhD, Uskudar University
  • Principal Investigator: Nazlı H Gözütok, Uskudar University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 29, 2025

Primary Completion (Actual)

February 1, 2026

Study Completion (Actual)

February 1, 2026

Study Registration Dates

First Submitted

February 26, 2026

First Submitted That Met QC Criteria

March 10, 2026

First Posted (Actual)

March 13, 2026

Study Record Updates

Last Update Posted (Actual)

March 13, 2026

Last Update Submitted That Met QC Criteria

March 10, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 61351342/020-1603

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postmenopausal Period

Clinical Trials on High-intensity functional exercise

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe